Skip to main content

Table 2 Anatomic sites of soft tissue metastases: Lesion level evaluation

From: Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

Anatomic site of disease

Visceral involvement (n, %)

No Visceral involvement

(n, %)

Total

126

120

Bone soft tissue

17 (13.5)

56 (46.7)

Local residual/recurrent disease

2 (1.6)

4 (3.3)

Lymph Node

34 (27.0)

60 (50.0)

Visceral disease

73 (57.9)

0

-Liver

33 (26.2)

0

-Lung

22 (17.5)

0

-Adrenal

12 (9.5)

0

-Spleen

2 (1.6)

0

-Peritoneal nodule

1 (0.8)

0

-Pleura

1 (0.8)

0

-Kidney

2 (1.6)

0